Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$1.53B |
| 2 |
Procter & Gamble
PG
|
+$1.01B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$684M |
| 4 |
Zoom
ZM
|
+$534M |
| 5 |
Chewy
CHWY
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.07B |
| 2 |
ServiceNow
NOW
|
+$874M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$776M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$767M |
| 5 |
Apple
AAPL
|
+$719M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.32% |
| 2 | Healthcare | 10.4% |
| 3 | Consumer Discretionary | 8.1% |
| 4 | Communication Services | 7.82% |
| 5 | Financials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALNA
3651
DELISTED
Allena Pharmaceuticals
ALNA
| $1.71M | ﹤0.01% |
1,080,385
-173,462
| -14% | -$291K |
|
3652
Avient
AVNT
$3.94B
| $1.7M | ﹤0.01% |
64,947
-348,954
| -84% | -$8.1M |
|
|
IPFF
3653
DELISTED
iShares International Preferred Stock ETF
IPFF
| $1.7M | ﹤0.01% |
134,042
+5,515
| +4% | +$65.6K |
|
3654
Ennis
EBF
$570M
| $1.7M | ﹤0.01% |
93,614
+48,108
| +106% | +$848K |
|
3655
Adecoagro
AGRO
$1.36B
| $1.7M | ﹤0.01% |
391,042
+177,498
| +83% | +$742K |
|
3656
Axogen
AXGN
$2.39B
| $1.7M | ﹤0.01% |
183,515
+118,814
| +184% | +$1.06M |
|
|
PFO
3657
Flaherty & Crumrine Preferred and Income Opportunity Fund
PFO
$119M
| $1.7M | ﹤0.01% |
152,389
-1,248
| -0.8% | -$13.8K |
|
3658
Cytosorbents Corp
CTSO
$24.8M
| $1.7M | ﹤0.01% |
171,158
-91,978
| -35% | -$845K |
|
|
NSL
3659
DELISTED
NUVEEN SENIOR INCM FD
NSL
| $1.69M | ﹤0.01% |
360,004
-455,472
| -56% | -$2.08M |
|
|
TGI
3660
DELISTED
Triumph Group
TGI
| $1.69M | ﹤0.01% |
187,191
-2,265
| -1% | -$16.8K |
|
|
DAO
3661
Youdao
DAO
$2.11B
| $1.69M | ﹤0.01% |
44,934
+18,482
| +70% | +$455K |
|
3662
Champion Homes
SKY
$5.02B
| $1.68M | ﹤0.01% |
69,189
+34,329
| +98% | +$715K |
|
|
FOCL
3663
EDAP TMS S.A.
FOCL
$233M
| $1.68M | ﹤0.01% |
680,210
+130,267
| +24% | +$312K |
|
3664
Greif
GEF
$5.11B
| $1.68M | ﹤0.01% |
48,961
+6,582
| +16% | +$216K |
|
3665
DXP Enterprises
DXPE
$2.93B
| $1.68M | ﹤0.01% |
84,481
-147,014
| -64% | -$2.37M |
|
|
CAMP
3666
DELISTED
CalAmp Corp.
CAMP
| $1.68M | ﹤0.01% |
9,125
+3,597
| +65% | +$556K |
|
|
DBD
3667
DELISTED
Diebold Nixdorf Incorporated
DBD
| $1.68M | ﹤0.01% |
276,851
+49,869
| +22% | +$246K |
|
3668
EnerSys
ENS
$6.93B
| $1.68M | ﹤0.01% |
26,025
-8,242
| -24% | -$485K |
|
|
GTS
3669
DELISTED
Triple-S Management Corporation
GTS
| $1.68M | ﹤0.01% |
88,133
-66,408
| -43% | -$1.14M |
|
|
AGEN
3670
Agenus
AGEN
$309M
| $1.67M | ﹤0.01% |
21,700
+3,815
| +21% | +$228K |
|
3671
Teekay
TK
$988M
| $1.67M | ﹤0.01% |
697,000
+626,648
| +891% | +$1.92M |
|
3672
Washington Trust Bancorp
WASH
$748M
| $1.67M | ﹤0.01% |
51,022
+9,432
| +23% | +$308K |
|
3673
Nuveen Massachusetts Quality Municipal Income Fund
NMT
$129M
| $1.67M | ﹤0.01% |
121,434
-33,725
| -22% | -$445K |
|
3674
Invesco Bloomberg MVP Multi-factor ETF
BMVP
$105M
| $1.67M | ﹤0.01% |
56,571
-23,007
| -29% | -$634K |
|
|
BTA
3675
DELISTED
BlackRock Long-Term Municipal Advantage Trust
BTA
| $1.66M | ﹤0.01% |
140,371
+3,146
| +2% | +$35.2K |
|
Similar funds
Morgan Stanley's Q2 2020 Portfolio in Review
As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,644 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
- Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
- Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
- Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
- Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
- Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
- Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.
Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.